QHSLab Inc Financials

USAQ

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows QHSLab Inc (USAQ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Key Financial Metrics

Revenue

$2.1M

YoY+51.3%

QHSLab Inc generated $2.1M in revenue in fiscal year 2024. This represents an increase of 51.3% from the prior year.

EBITDA

$352K

YoY+476.5%

QHSLab Inc's EBITDA was $352K in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 476.5% from the prior year.

Free Cash Flow

N/A

Net Income

-$259K

YoY+44.6%

QHSLab Inc reported -$259K in net income in fiscal year 2024. This represents an increase of 44.6% from the prior year.

EPS (Diluted)

$-0.03

YoY+40.0%

QHSLab Inc earned $-0.03 per diluted share (EPS) in fiscal year 2024. This represents an increase of 40.0% from the prior year.

Cash & Debt

$157K

YoY+204.7%

5Y CAGR+46.1%

QHSLab Inc held $157K in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

11M

YoY+11.0%

5Y CAGR+13.4%

10Y CAGR+25.8%

QHSLab Inc had 11M shares outstanding in fiscal year 2024. This represents an increase of 11.0% from the prior year.

Gross Margin

63.7%

YoY+7.4pp

QHSLab Inc's gross margin was 63.7% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 7.4 percentage points from the prior year.

Operating Margin

9.7%

YoY+26.7pp

QHSLab Inc's operating margin was 9.7% in fiscal year 2024, reflecting core business profitability. This is up 26.7 percentage points from the prior year.

Net Margin

-12.2%

YoY+21.1pp

QHSLab Inc's net profit margin was -12.2% in fiscal year 2024, showing the share of revenue converted to profit. This is up 21.1 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

$294K

YoY+37.6%

5Y CAGR+24.1%

QHSLab Inc invested $294K in research and development in fiscal year 2024. This represents an increase of 37.6% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

USAQ Income Statement

Metric	FY24	FY24	FY23	FY22	FY21	FY20
Revenue	$2.1M+51.3%	$1.4M+13.3%	$1.2M-12.1%	$1.4M+1035.8%	$125K	N/A
Cost of Revenue	$774K+25.8%	$615K-1.3%	$624K-16.1%	$744K+899.0%	$74K	N/A
Gross Profit	$1.4M+71.1%	$794K+28.1%	$620K-7.6%	$671K+1239.0%	$50K	N/A
R&D Expenses	$294K+37.6%	$214K+12.6%	$190K+109.2%	$91K-7.5%	$98K-1.9%	$100K
SG&A Expenses	$276K+6.7%	$259K-33.1%	$388K-14.6%	$454K+244.6%	$132K+144.6%	$54K
Operating Income	$206K+185.7%	-$240K+57.2%	-$561K-11.6%	-$502K-82.6%	-$275K-78.5%	-$154K
Interest Expense	$465K+101.8%	$230K-46.8%	$433K+75.8%	$246K+695.5%	$31K+149.5%	$12K
Income Tax	N/A	N/A	$0	N/A	N/A	N/A
Net Income	-$259K+44.6%	-$468K+53.0%	-$996K-29.3%	-$770K-135.2%	-$327K-96.6%	-$167K
EPS (Diluted)	$-0.03+40.0%	$-0.05+54.5%	$-0.11	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	$737K+21.7%	$605K-6.2%	$645K+3.1%	$626K+15.0%	$544K+15.1%	$473K-3.2%	$489K+55.1%	$315K
Cost of Revenue	$243K+17.9%	$206K-4.2%	$215K+0.8%	$214K+19.4%	$179K+0.3%	$179K-11.8%	$202K+61.8%	$125K
Gross Profit	$494K+23.7%	$399K-7.2%	$430K+4.3%	$412K+12.9%	$365K+24.0%	$294K+2.9%	$286K+50.7%	$190K
R&D Expenses	$133K+18.2%	$112K-9.4%	$124K+15.3%	$108K+35.3%	$80K+22.7%	$65K+52.0%	$43K-4.2%	$45K
SG&A Expenses	$64K-35.1%	$99K-36.6%	$156K+86.5%	$83K+49.7%	$56K+17.4%	$47K-47.2%	$90K+68.7%	$53K
Operating Income	$96K+735.1%	$12K+195.7%	-$12K-116.5%	$73K-18.0%	$89K+197.3%	$30K+120.3%	$14K+128.1%	-$48K
Interest Expense	$63K-2.5%	$64K-4.6%	$68K-81.3%	$361K+817.3%	$39K+19.7%	$33K+2.3%	$32K-15.9%	$38K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$33K+163.1%	-$53K+33.5%	-$80K+72.3%	-$288K-677.9%	$50K+1822.0%	-$3K+84.4%	-$19K+78.6%	-$87K
EPS (Diluted)	$0.00	$0.00+100.0%	$-0.01+66.7%	$-0.03	$0.00	$0.00	$0.00+100.0%	$-0.01

USAQ Balance Sheet

Metric	FY24	FY24	FY23	FY22	FY21	FY20
Total Assets	$1.8M+7.0%	$1.7M-14.1%	$2.0M-11.4%	$2.2M+641.4%	$298K+1030.8%	$26K
Current Assets	$421K+169.5%	$156K-45.3%	$286K-35.9%	$446K+67.5%	$266K+910.5%	$26K
Cash & Equivalents	$157K+204.7%	$52K-71.1%	$179K-37.7%	$287K+204.1%	$94K+299.9%	$24K
Inventory	$42K+65.9%	$25K-51.4%	$52K-21.1%	$66K-34.1%	$100K	N/A
Accounts Receivable	$196K+174.7%	$71K+49.5%	$48K-32.3%	$70K+16.4%	$61K	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.4M+17.0%	$2.1M+9.3%	$1.9M+35.9%	$1.4M+52.8%	$906K+98.7%	$456K
Current Liabilities	$2.4M+17.0%	$2.1M+20.5%	$1.7M+95.1%	$875K+307.7%	$215K+924.8%	$21K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$608K-61.8%	-$376K-592.6%	$76K-90.7%	$824K+235.5%	-$608K-41.5%	-$430K
Retained Earnings	-$4.3M-8.7%	-$4.0M-13.3%	-$3.5M-39.5%	-$2.5M-44.0%	-$1.7M-23.0%	-$1.4M

Metric	Q3'25	Q2'25	Q1'25	Q3'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$1.7M+1.4%	$1.7M+2.5%	$1.7M-7.3%	$1.8M+2.0%	$1.8M+3.9%	$1.7M-1.9%	$1.7M+3.0%	$1.7M
Current Assets	$429K+11.0%	$386K+18.5%	$326K-22.6%	$421K+20.5%	$349K+41.9%	$246K+1.5%	$242K+55.3%	$156K
Cash & Equivalents	$158K-5.9%	$168K+175.7%	$61K-61.1%	$157K+63.8%	$96K-7.9%	$104K+55.7%	$67K+29.8%	$52K
Inventory	$27K-37.0%	$42K+44.8%	$29K-30.1%	$42K+4.4%	$40K+543.9%	$6K-83.2%	$37K+47.4%	$25K
Accounts Receivable	$210K+41.8%	$148K-24.0%	$195K-0.6%	$196K-1.1%	$198K+50.7%	$132K+0.5%	$131K+83.4%	$71K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.3M-0.4%	$2.4M+4.2%	$2.3M-6.1%	$2.4M+14.6%	$2.1M+0.8%	$2.1M-1.4%	$2.1M+2.7%	$2.1M
Current Liabilities	$2.3M-0.4%	$2.4M+4.2%	$2.3M-6.1%	$2.4M+15.2%	$2.1M+0.3%	$2.1M-1.4%	$2.1M+2.7%	$2.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$611K+5.2%	-$644K-9.0%	-$591K+2.7%	-$608K-81.3%	-$335K+12.9%	-$385K-0.8%	-$382K-1.7%	-$376K
Retained Earnings	-$4.4M+0.7%	-$4.5M-1.2%	-$4.4M-1.8%	-$4.3M-7.9%	-$4.0M+1.2%	-$4.1M-1.6%	-$4.0M-0.5%	-$4.0M

USAQ Cash Flow Statement

Metric	FY24	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$142K+189.2%	-$160K+54.5%	-$351K+1.1%	-$355K-114.3%	-$166K-22.8%	-$135K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	-$37K+76.0%	-$155K-387.6%	-$32K	N/A
Financing Cash Flow	-$37K-213.3%	$33K-88.4%	$280K-60.1%	$702K+161.9%	$268K+69.2%	$158K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	N/A	N/A	-$50K	N/A	N/A	N/A	$57K	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	-$47K	N/A	N/A	N/A	-$41K	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

USAQ Financial Ratios

Metric	FY24	FY24	FY23	FY22	FY21	FY20
Gross Margin	63.7%+7.4pp	56.3%+6.5pp	49.8%+2.4pp	47.4%+7.2pp	40.2%	N/A
Operating Margin	9.7%+26.7pp	-17.0%+28.1pp	-45.1%-9.6pp	-35.5%+185.4pp	-220.9%	N/A
Net Margin	-12.2%+21.1pp	-33.2%+46.9pp	-80.1%-25.7pp	-54.4%+208.4pp	-262.9%	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-14.4%+13.4pp	-27.9%+23.0pp	-50.9%-16.0pp	-34.9%+75.0pp	-109.9%+522.3pp	-632.2%
Current Ratio	0.17+0.1	0.08-0.1	0.17-0.3	0.51-0.7	1.24-0.0	1.26
Debt-to-Equity	-3.96+1.5	-5.48-30.1	24.67+23.0	1.68+3.2	-1.49-0.4	-1.06
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	67.0%+1.1pp	65.9%-0.7pp	66.6%+0.8pp	65.8%-1.2pp	67.1%+4.8pp	62.2%+3.7pp	58.6%-1.7pp	60.3%
Operating Margin	13.1%+11.2pp	1.9%+3.8pp	-1.9%-13.5pp	11.7%-4.7pp	16.4%+10.0pp	6.3%+3.5pp	2.8%+18.1pp	-15.4%
Net Margin	4.5%+13.3pp	-8.8%+3.6pp	-12.3%+33.6pp	-45.9%-55.1pp	9.1%+9.7pp	-0.6%+3.2pp	-3.8%+23.7pp	-27.5%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	1.9%+5.0pp	-3.1%+1.7pp	-4.8%+11.2pp	-16.0%-18.8pp	2.8%+3.0pp	-0.2%+0.9pp	-1.1%+4.1pp	-5.1%
Current Ratio	0.18+0.0	0.16+0.0	0.14-0.0	0.170.0	0.17+0.0	0.120.0	0.11+0.0	0.08
Debt-to-Equity	-3.84-0.2	-3.65+0.2	-3.82+0.1	-3.96+2.3	-6.26-0.9	-5.41+0.1	-5.53-0.1	-5.48
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$608K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.17), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Financial Health Signals

Altman Z-Score Distress

-2.68

Bankruptcy risk indicator. Above 2.99 = safe, below 1.81 = distress.

Piotroski F-Score Neutral

6/9

Financial strength trend (9 signals). 7-9 = strong, 0-3 = weak.

Earnings Quality Mixed

-0.55x

Operating cash flow vs net income. Above 1.0x = cash-backed earnings.

Interest Coverage At Risk

0.4x

Operating income vs interest expense. Above 5x = safe, below 2x = risky.

Similar Companies

Ir-Med Inc IRME

$2.1M

Therma Bright Inc TBRIF

$2.3M

Bionoid Pharma Inc BINP

$1.6M

Cyduct Diagnostics Inc CYDX

$1.3M

Kelyniam Global Inc KLYG

$3.5M

Frequently Asked Questions

What is QHSLab Inc's annual revenue?

QHSLab Inc (USAQ) reported $2.1M in total revenue for fiscal year 2024. This represents a 51.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is QHSLab Inc's revenue growing?

QHSLab Inc (USAQ) revenue grew by 51.3% year-over-year, from $1.4M to $2.1M in fiscal year 2024.

Is QHSLab Inc profitable?

No, QHSLab Inc (USAQ) reported a net income of -$259K in fiscal year 2024, with a net profit margin of -12.2%.

What is QHSLab Inc's earnings per share (EPS)?

QHSLab Inc (USAQ) reported diluted earnings per share of $-0.03 for fiscal year 2024. This represents a 40.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is QHSLab Inc's EBITDA?

QHSLab Inc (USAQ) had EBITDA of $352K in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is QHSLab Inc's gross margin?

QHSLab Inc (USAQ) had a gross margin of 63.7% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is QHSLab Inc's operating margin?

QHSLab Inc (USAQ) had an operating margin of 9.7% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is QHSLab Inc's net profit margin?

QHSLab Inc (USAQ) had a net profit margin of -12.2% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is QHSLab Inc's operating cash flow?

QHSLab Inc (USAQ) generated $142K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are QHSLab Inc's total assets?

QHSLab Inc (USAQ) had $1.8M in total assets as of fiscal year 2024, including both current and long-term assets.

How much does QHSLab Inc spend on research and development?

QHSLab Inc (USAQ) invested $294K in research and development during fiscal year 2024.

How many shares does QHSLab Inc have outstanding?

QHSLab Inc (USAQ) had 11M shares outstanding as of fiscal year 2024.

What is QHSLab Inc's current ratio?

QHSLab Inc (USAQ) had a current ratio of 0.17 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is QHSLab Inc's debt-to-equity ratio?

QHSLab Inc (USAQ) had a debt-to-equity ratio of -3.96 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is QHSLab Inc's return on assets (ROA)?

QHSLab Inc (USAQ) had a return on assets of -14.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Why is QHSLab Inc's debt-to-equity ratio negative or unusual?

QHSLab Inc (USAQ) has negative shareholder equity of -$608K as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is QHSLab Inc's Altman Z-Score?

QHSLab Inc (USAQ) has an Altman Z-Score of -2.68, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress.

What is QHSLab Inc's Piotroski F-Score?

QHSLab Inc (USAQ) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals.

Are QHSLab Inc's earnings high quality?

QHSLab Inc (USAQ) has an earnings quality ratio of -0.55x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation.

Can QHSLab Inc cover its interest payments?

QHSLab Inc (USAQ) has an interest coverage ratio of 0.4x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline.